Ryvu Therapeutics S.A. logo

Ryvu Therapeutics S.A.

WSE:RVU.WA

Overview | Financials
Company Name Ryvu Therapeutics S.A.
Symbol RVU.WA
Currency PLN
Price 64.5
Market Cap 1,490,987,934
Dividend Yield 0%
52-week-range 49.2 - 72.4
Industry Biotechnology
Sector Healthcare
CEO Mr. Pawel Tadeusz Przewiezlikowski M.B.A., M.Sc.
Website https://www.ryvu.com

An error occurred while fetching data.

About Ryvu Therapeutics S.A.

Ryvu Therapeutics S.A., a clinical stage biopharmaceutical company, engages in developing of novel small molecule therapies for treatment in oncology. Its lead candidate, RVU120, is a CDK8 kinase inhibitor with potential for development in hematological malignancies and solid tumors, which is in Phase 1b study for the treatment of acute

Related Stocks

Captor Therapeutics Spolka Akcyjna logo

Captor Therapeutics Spolka Akcyjna

CTX.WA

105 PLN

Mercator Medical S.A. logo

Mercator Medical S.A.

MRC.WA

41.48 PLN

Mabion S.A. logo

Mabion S.A.

MAB.WA

19.28 PLN

BIOTON S.A. logo

BIOTON S.A.

BIO.WA

3.64 PLN

Celon Pharma S.A. logo

Celon Pharma S.A.

CLN.WA

15.96 PLN

Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

MDG.WA

32.35 PLN

Selvita S.A. logo

Selvita S.A.

SLV.WA

59.7 PLN

NEUCA S.A. logo

NEUCA S.A.

NEU.WA

843 PLN

Financials

Numbers are in millions USD

Numbers are in millions USD